Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.

Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):90-99.

View in: PubMed

subject areas

Age Factors
Aged
Aged, 80 and over
Carbon Dioxide
Carcinoma, Non-Small-Cell Lung
Comorbidity
Disease Progression
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Lung Neoplasms
Male
Middle Aged
Neoplasm Recurrence, Local
Nomograms
Proportional Hazards Models
Pulmonary Diffusing Capacity
Radiosurgery
Regression Analysis
ROC Curve
Sex Factors
Treatment Outcome

authors with profiles

JOE Y CHANG
JAMES WELSH
Hanwen Arnold Feng